What conditions qualify for medical cannabis in Kentucky?

Kentucky's six statutory qualifying conditions are: cancer (any type), chronic pain (severe/intractable/debilitating), epilepsy (intractable seizure disorders), multiple sclerosis, chronic nausea (resistant to conventional treatment), and PTSD. The UK Cannabis Center can also approve additional conditions.

Is chronic pain a qualifying condition in Kentucky?

Yes. Chronic pain that is severe, intractable, or debilitating qualifies for medical cannabis in Kentucky. This is the broadest qualifying category and encompasses conditions like back pain, neuropathy, and arthritis.

Will Kentucky add more qualifying conditions?

Potentially. In February 2026, the UK Cannabis Center recommended 16 additional conditions including Crohn's disease, fibromyalgia, glaucoma, Parkinson's, ALS, HIV/AIDS, and sickle cell disease. These recommendations await legislative action.

Does anxiety qualify for medical cannabis in Kentucky?

Not currently. Anxiety disorders are among the 16 conditions recommended by the UK Cannabis Center in February 2026, but the recommendation has not yet been approved by the legislature. Currently, only PTSD qualifies among psychiatric conditions.

Kentucky Medical Cannabis Qualifying Conditions

Medical Disclaimer: This information is educational only and does not constitute medical advice. Cannabis affects everyone differently. Always consult a qualified healthcare provider before using cannabis, especially if you take other medications.

Last verified: April 2026

Current Qualifying Conditions

Senate Bill 47 established six statutory qualifying conditions for Kentucky's medical cannabis program. Additionally, the law created a pathway for the University of Kentucky Cannabis Center to approve additional conditions based on scientific evidence.

Condition	Details
Cancer	Any type or form, regardless of stage
Chronic pain	Severe, intractable, or debilitating
Epilepsy	Any intractable seizure disorder
Multiple sclerosis	Including muscle spasms and spasticity
Chronic nausea	Cyclical vomiting syndrome, resistant to conventional treatment
PTSD	Post-traumatic stress disorder
Other	Any condition approved by the Kentucky Center for Cannabis (UK)

Understanding the Conditions

Cancer

Any type or form of cancer qualifies, regardless of stage. Patients may seek medical cannabis for cancer-related symptoms including pain, nausea from chemotherapy, appetite loss, and insomnia. No specific staging or prognosis documentation is required beyond a confirmed diagnosis.

Chronic Pain

The broadest qualifying category. Chronic pain must be severe, intractable, or debilitating and documented in the patient's medical history. This condition encompasses a wide range of diagnoses including back pain, neuropathy, arthritis, and other conditions that cause persistent pain. Given Kentucky's opioid crisis, chronic pain patients represent a significant portion of the program's registry.

Epilepsy

Any intractable seizure disorder qualifies. Kentucky's inclusion of epilepsy reflects the growing body of evidence supporting cannabinoid therapy for seizure management. The FDA-approved cannabidiol medication Epidiolex has been available since 2018, but some patients prefer whole-plant cannabis products.

Multiple Sclerosis

MS patients qualify for medical cannabis, with the condition specifically noting muscle spasms and spasticity as treatable symptoms. Cannabis-based medications for MS spasticity are approved in several countries outside the United States.

Chronic Nausea

Includes cyclical vomiting syndrome and nausea that is resistant to conventional treatment. This condition must be documented as unresponsive to standard antiemetic therapies before cannabis certification is appropriate.

PTSD

Post-traumatic stress disorder qualifies without restriction on the type of trauma or duration of symptoms. Given Kentucky's large veteran population and the stories that drove SB 47's passage — including veteran Jared Bonvell's testimony — PTSD is a central qualifying condition.

The UK Cannabis Center Pathway

SB 47 created a unique mechanism: the University of Kentucky Center for Cannabis Research and Innovation (commonly called the Kentucky Cannabis Center or UK Cannabis Center) has the authority to recommend additional qualifying conditions based on peer-reviewed scientific evidence. This approach allows the list to expand without requiring new legislation.

Pending Expansion: 16 New Conditions

In February 2026, the UK Cannabis Center recommended 16 additional qualifying conditions for inclusion in the program. These recommendations are based on clinical evidence reviews and await legislative action to become effective:

Recommended Condition	Category
Crohn's disease	Gastrointestinal
Fibromyalgia	Pain/Musculoskeletal
Glaucoma	Ophthalmologic
Parkinson's disease	Neurological
ALS (amyotrophic lateral sclerosis)	Neurological
HIV/AIDS	Immunological
Sickle cell disease	Hematological
Ulcerative colitis	Gastrointestinal
Cachexia/wasting syndrome	Metabolic
Huntington's disease	Neurological
Tourette syndrome	Neurological
Autism spectrum disorder	Neurodevelopmental
Traumatic brain injury	Neurological
Spinal cord injury	Neurological
Anxiety disorders	Psychiatric
Terminal illness (any)	General

If approved, these additions would bring Kentucky's qualifying conditions more in line with states like Ohio and Illinois, which maintain broader lists. The timeline for legislative action remains uncertain.

Certification Process

To qualify for medical cannabis, patients must:

Have a documented diagnosis of a qualifying condition in their medical records
Receive a written certification from a registered practitioner (one of 519 currently in the system)
Obtain a confirming diagnosis from a second practitioner
The certifying practitioner must have an established patient relationship, not a first-time telehealth appointment

For the complete step-by-step application process, see How to Get a Card.